None listed
Conditions
Interventions
Intervention1: Essen Merry Glow: Route of Administration : Oral
Formulation : Liquid
Dose : 35.71g (1 packet) in 150 ml cold water 45-60 minutes before bedtime
Dosage : OD for 3 months
Control Interv
Sponsors
Essen Fooddies India Pvt Ltd
Aurous HealthCare Research and Development India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinically healthy adults, between the ages of 30 and 65 years (both ages and all genders inclusive) looking to improve their skin, nail and hair health. 2. Subjects with any skin type who along with fine lines and wrinkles must have any one of the following concerns. i. Dry Hair ii. Dull Hair iii. Brittle and Thin Hair including hair breakage iv. Brittle Nails 3. Subjects who are willing to abstain from use of herbal, allopathic or other nutritional supplements that are indicated at improving skin, hair and nail health. 4. Subjects who are willing to give informed consent for participation, able to comprehend and understand the responsibilities during screening and treatment period. 5. Subjects who are willing not to participate in any other clinical trial during participation in the current trial.
Exclusion criteria
Exclusion criteria: 1. Subjects with known hypersensitivity or ethical objection to the ingredients of the investigational product 2. Subjects who have no dermatological condition of the skin, nail or hair that impedes with basic physical examination or determination of efficacy of investigational product on the skin. 3. Subjects who on active treatment for skin, hair and/or nail conditions 4. Subjects who have nail biting habit. 5. Subjects on remission from cancer of any type less than 5 years at the time of screening 6. Subjects who are planning a pregnancy and/or currently breastfeeding. 7. Subjects who have participated in a clinical study less than 1 month before screening. 8. Any significant medical condition (e.g., significant psychiatric or neurological disorders, active alcohol/drug abuse, etc.), any medical condition that is unstable/poorly controlled or other factor (e.g., planned relocation) that the Investigator felt would interfere with study evaluations and study participation. 9. Subjects who mentally unable to comprehend the responsibilities and adhere to the stipulations of the protocol. 10. Subjects, who in the opinion of the Investigator are not eligible for enrolment in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Skin Health : Clinical Grading : Decrease of 50% in Total Score from Baseline 2. Hair Health : m-Hair Health Assessment : Decrease of 50% in Total Score from Baseline 3. Nail Health : Brittle Nail Assessment : Increase of 20% of the Total Score from Baseline 4. Patient’s Global Impression Scale : Score of 4 at end of the study Timepoint: 1. Skin Health : Clinical Grading : Day 1, Day 45, Day 90 2. Hair Health : m-Hair Health Assessment : Day 1, Day 45, Day 90 3. Nail Health : Brittle Nail Assessment : Day 1, Day 45, Day 90 4. Patient’s Global Impression Scale : Day 90 | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: None | — |
Countries
India
Contacts
Public ContactDr VT Sriraam
Aurous HealthCare R&D India Pvt. Ltd.
Outcome results
None listed